FDA Inspection 1261728 - Braintree, A part of SEBELA Pharmaceuticals - March 07, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Braintree, A part of SEBELA Pharmaceuticals, with an inspection on March 7, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Braintree, A part of SEBELA Pharmaceuticals
Inspection Date: March 7, 2025
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 4b903c68-595f-4b48-a387-1c742007f850